The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: A large proportion of colorectal cancers are thought to be associated with unhealthy dietary and lifestyle exposures, particularly energy excess, obesity, hyperinsulinemia, and hyperglycemia. It has been suggested that these processes stimulate the production of toxic reactive carbonyls from sugars such as glyceraldehyde. Glyceraldehyde contributes to the production of a group of compounds known as glyceraldehyde-derived advanced glycation end-products (glycer-AGEs), which may promote colorectal cancer through their proinflammatory and pro-oxidative properties. The objective of this study nested within a prospective cohort was to explore the association of circulating glycer-AGEs with risk of colorectal cancer. Methods: A total of 1,055 colorectal cancer cases (colon n = 659; rectal n = 396) were matchced (1:1) to control subjects. Circulating glycer-AGEs were measured by a competitive ELISA. Multivariable conditional logistic regression models were used to calculate ORs and 95% confidence intervals (95% CI), adjusting for potential confounding factors, including smoking, alcohol, physical activity, body mass index, and diabetes status. Results: Elevated glycer-AGEs levels were not associated with colorectal cancer risk (highest vs. lowest quartile, 1.10; 95% CI, 0.82–1.49). Subgroup analyses showed possible divergence by anatomical subsites (OR for colon cancer, 0.83; 95% CI, 0.57–1.22; OR for rectal cancer, 1.90; 95% CI, 1.14–3.19; Pheterogeneity = 0.14). Conclusions: In this prospective study, circulating glycer-AGEs were not associated with risk of colon cancer, but showed a positive association with the risk of rectal cancer. Impact: Further research is needed to clarify the role of toxic products of carbohydrate metabolism and energy excess in colorectal cancer development. Cancer Epidemiol Biomarkers Prev; 24(12); 1855–63. ©2015 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597 · cited 1×
“They belong to the larger family of advanced glycation endproducts (AGEs), which are stable end-products of the nonenzymatic glycation reaction between reactive carbonyls and free amino groups of proteins, lipids, or nucleic acids (10, 11).”
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261 · cited 1×
“They belong to the larger family of advanced glycation endproducts (AGEs), which are stable end-products of the nonenzymatic glycation reaction between reactive carbonyls and free amino groups of proteins, lipids, or nucleic acids (10, 11).”
Riboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866 · cited 2×
“Diet over the previous 12 months was assessed at recruitment by validated country-specific questionnaires designed to ensure high compliance and improved measures of local dietary habits (39).”
Self-citationThe Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Advanced glycoxidation end products in commonly consumed foods
Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B. S., Uribarri, J., & Vlassara, H. (2004) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.05.214 · Cited by 744
Murphy, N., Norat, T., Ferrari, P., Jenab, M., Bueno-de-Mesquita, B., Skeie, G., Dahm, C. C., Overvad, K., Olsen, A., Tjønneland, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039361 · Cited by 271 · cited 1×
“(g/day), and red/processed meats (g/day) (43-48), and diabetes status (49, 50).”
Self-citationTAGE (toxic AGEs) hypothesis in various chronic diseases
Takeuchi, M., & Yamagishi, S. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.042 · Cited by 116 · cited 1×
“group of AGEs, also referred to as toxic-AGEs (14).”
Self-citationShort-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells
Yamamoto, Y., Yonekura, H., Watanabe, T., Sakurai, S., Li, H., Harashima, A., Myint, K. M., Osawa, M., Takeuchi, A., Takeuchi, M., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.030 · Cited by 44 · cited 7×
“In addition to their potential direct effects, some evidence indicates that glycer-AGEs interact strongly with the receptor for AGEs (RAGE) to cause inflammatory and oxidative responses (28, 34)—which are suspected in the development of various cancers, including colorectal cancer (35–37).”
InfluentialSelf-citation
Cited by
Perrone, A., Giovino, A., Benny, J., & Martinelli, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3818196 · Cited by 459
El Hosry, L., Elias, V., Chamoun, V., Halawi, M., Cayot, P., Nehme, A., & Bou-Maroun, E. (2025) · Foods · doi:10.3390/foods14111881 · Cited by 400
Dietary advanced glycation end products and their relevance for human health
Nowotny, K., Schröter, D., Schreiner, M., & Grune, T. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.06.005 · Cited by 255
Role of advanced glycation end products in carcinogenesis and their therapeutic implications
Schröter, D., & Höhn, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130145549 · Cited by 126
Sakasai-Sakai, A., Takata, T., Takino, J.-I., & Takeuchi, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14711-3 · Cited by 46
Self-citation
Metadata
- Authors
- Kong, S. Y., Takeuchi, M., Hyogo, H., McKeown-Eyssen, G., Yamagishi, S.-I., Chayama, K., O'Brien, P. J., Ferrari, P., Overvad, K., Olsen, A., Tjønneland, A., Boutron-Ruault, M.-C., Bastide, N., Carbonnel, F., Kühn, T., Kaaks, R., Boeing, H., Aleksandrova, K., Trichopoulou, A., Lagiou, P., Vasilopoulou, E., Masala, G., Pala, V., Santucci De Magistris, M., Tumino, R., Naccarati, A., Bueno-de-Mesquita, H. B., Peeters, P. H., Weiderpass, E., Quirós, J. R., Jakszyn, P., Sánchez, M.-J., Dorronsoro, M., Gavrila, D., Ardanaz, E., Rutegård, M., Nyström, H., Wareham, N. J., Khaw, K.-T., Bradbury, K. E., Romieu, I., Freisling, H., Stavropoulou, F., Gunter, M. J., Cross, A. J., Riboli, E., Jenab, M., & Bruce, W. R.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2015-12-01
- Volume
- 24
- Issue
- 12
- Pages
- 1855-1863
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2147732842
- Cited by
- 40
- References
- 8
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk. https://app.cochat.ai/papers/10.1158/1055-9965.epi-15-0422
- The paper
- Kong, S. Y., Takeuchi, M., Hyogo, H., McKeown-Eyssen, G., Yamagishi, S.-I., Chayama, K., O'Brien, P. J., Ferrari, P., Overvad, K., Olsen, A., Tjønneland, A., Boutron-Ruault, M.-C., Bastide, N., Carbonnel, F., Kühn, T., Kaaks, R., Boeing, H., Aleksandrova, K., Trichopoulou, A., . . . Bruce, W. R. (2015). The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-15-0422
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.